Search Results for keywords:"Cancer Treatment"

Found 2 results

Search Results: keywords:"Cancer Treatment"

💰 Only
Oldest Newest
  • 2024-29076 — Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors for the Treatment of Cancer
    Type:Notice
    Citation:89 FR 99888
    Reading Time:about 3 minutes

    The National Cancer Institute (NCI), part of the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS), is planning to grant an exclusive license to StraightLine Bio, Inc. for certain anti-cancer inventions. These inventions involve patents related to T cell receptors targeting a cancer antigen called KK-LC-1, which is found in certain epithelial cancers. The proposed license would allow StraightLine Bio to develop and commercialize therapies using this technology worldwide, but with some specific exclusions. The public has a chance to comment or object to this plan until December 26, 2024.

    Simple Explanation

    The government wants to let one company use a special recipe to make medicine for some types of cancer, but people can say if they think it's a bad idea until the end of December 2024.

  • 2024-28081 — Prospective Grant of an Exclusive Patent License: Vaccine Augmented Tumor Infiltrating Lymphocytes for the Treatment of Cancer
    Type:Notice
    Citation:89 FR 95224
    Reading Time:about 3 minutes

    The National Institutes of Health is considering granting an Exclusive Patent License to Iovance Biotherapeutics, Inc. for inventions related to cancer treatment. This involves patents for a combination of T cell therapy and vaccination designed to boost the immune system's ability to fight cancer. The proposed license will cover the development and commercialization of these treatments for human cancer patients. The public can submit comments or objections to this proposal by December 17, 2024.

    Simple Explanation

    The National Institutes of Health is thinking about letting a company called Iovance Biotherapeutics use a special invention that helps the body fight cancer better. This means only Iovance can use this idea to make medicines, and people can tell the NIH what they think about this plan until December 17, 2024.